Corcept Therapeutics Inc’s filing revealed that its Director MAHONEY DAVID L acquired Company’s shares for reported $2.03 million on May 16 ’25. In the deal valued at $74.23 per share,27,352 shares were bought.
Then, Guyer William bought 20,000 shares, generating $1,483,400 in total proceeds.
Before that, Swisher Daniel N JR sold 2,200 shares. Corcept Therapeutics Inc shares valued at $158,526 were divested by the Director at a price of $72.06 per share. As a result of the transaction, Swisher Daniel N JR now holds 0 shares, worth roughly $0.0.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Monday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -0.35% to $74.82. Over the last five days, the stock has gained 3.72%. Corcept Therapeutics Inc shares have risen nearly 48.48% since the year began. Nevertheless, the stocks have risen 168.85% over the past one year.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-04-30, dropping by -3.34 million shares to a total of 13.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 16.53 million shares. There was a decline of -25.36%, which implies that there is a negative sentiment for the stock.
